Copyright
©The Author(s) 2019.
World J Hepatol. Mar 27, 2019; 11(3): 287-293
Published online Mar 27, 2019. doi: 10.4254/wjh.v11.i3.287
Published online Mar 27, 2019. doi: 10.4254/wjh.v11.i3.287
Table 3 Hemoglobin genotype breakdown between the extreme hyperbilirubinemia and control groups
| Hemoglobin SS (n) | Hemoglobin S Beta+ Thalassemia (n) | Hemoglobin S Beta null Thalassemia (n) | Hemoglobin S Beta (unknown) Thalassemia (n) | Hemoglobin SC (n) | |
| Extreme hyperbilirubinemia | 40 | 2 | 0 | 0 | 0 |
| Control | 33 | 11 | 2 | 2 | 51 |
- Citation: Haydek JP, Taborda C, Shah R, Reshamwala PA, McLemore ML, Rassi FE, Chawla S. Extreme hyperbilirubinemia: An indicator of morbidity and mortality in sickle cell disease. World J Hepatol 2019; 11(3): 287-293
- URL: https://www.wjgnet.com/1948-5182/full/v11/i3/287.htm
- DOI: https://dx.doi.org/10.4254/wjh.v11.i3.287